NKCC
NKCC(Na-K-Cl协同转运蛋白)
NKCC (Na-K-Cl cotransporter) is an electrically silent membrane-bound channels that mediates Na and Cl reabsorption. It functions in regulating cell volume and ionic balance.
NKCC 相关产品(7)
- GC12970FurosemideCAS: 54-31-9纯度: >99.50% / >98.00%
A loop diuretic and an inhibitor of NKCC1 and NKCC2
- GC36091Furosemide sodiumCAS: 41733-55-5纯度: >99.50%
A loop diuretic and an inhibitor of NKCC1 and NKCC2
- GC46957Bumetanide-d5CAS: 1216739-35-3纯度: >99.00%
An internal standard for the quantification of bumetanide
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC12970 | Furosemide | 54-31-9 | >99.50% / >98.00% | |
A loop diuretic and an inhibitor of NKCC1 and NKCC2 | ||||
| GC15524 | Bumetanide | 28395-03-1 | >99.50% | |
An NKCC1 inhibitor | ||||
| GC14041 | Ethacrynic Acid | 58-54-8 | >98.00% | |
Ethacrynic Acid是一种强效的、口服有效的袢利尿剂。 | ||||
| GC16795 | DCA | 2156-56-1 | >99.00% / >98.00% | |
DCA 是癌细胞中的代谢调节剂'；具有抗癌活性的线粒体。 DCA 抑制 PDHK，导致肿瘤微环境中的乳酸减少。 DCA 增加活性氧 (ROS) 生成并促进癌细胞凋亡。 DCA 也可作为 NKCC 抑制剂。 | ||||
| GC36091 | Furosemide sodium | 41733-55-5 | >99.50% | |
A loop diuretic and an inhibitor of NKCC1 and NKCC2 | ||||
| GC38738 | Azosemide | 27589-33-9 | >97.00% | |
Azosemide is a potent Na+–K+–2Cl? cotransporter NKCC1 inhibitor with IC50s of 0.246??M for hNKCC1A and 0.197??M for NKCC1B, respectively. | ||||
| GC46957 | Bumetanide-d5 | 1216739-35-3 | >99.00% | |
An internal standard for the quantification of bumetanide | ||||